Comparative Pharmacology
Head-to-head clinical analysis: BEEPEN VK versus PENICILLIN G POTASSIUM.
Peer-Reviewed Evidence
Head-to-head clinical analysis: BEEPEN VK versus PENICILLIN G POTASSIUM.
BEEPEN-VK vs PENICILLIN G POTASSIUM
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Penicillin V potassium is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs). This disrupts the cross-linking of peptidoglycan chains, leading to cell lysis and death. It is bactericidal against susceptible organisms.
Bactericidal: inhibits transpeptidases (penicillin-binding proteins) involved in bacterial cell wall synthesis, leading to cell lysis.
250-500 mg orally every 6 hours for mild to moderate infections; 500 mg orally every 6 hours for severe infections; maximum 4 g/day.
1-4 million units IV every 4-6 hours; maximum 24 million units/day
None Documented
None Documented
Terminal elimination half-life is 0.7-1.4 hours in patients with normal renal function; prolonged to 3-20 hours in severe renal impairment (CrCl <10 mL/min).
0.5-1 hour in normal renal function; prolonged to 3-10 hours in anuria/end-stage renal disease.
Primarily renal (70-80% as unchanged drug), with minor biliary/fecal excretion. Renal clearance is via tubular secretion and glomerular filtration.
Renal (60-90% as unchanged drug via tubular secretion and glomerular filtration); biliary (minor, <10%); fecal (minimal, <5%).
Category C
Category A/B
Penicillin Antibiotic
Penicillin Antibiotic